Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter - Trial NCT06333327
Access comprehensive clinical trial information for NCT06333327 through Pure Global AI's free database. This phase not specified trial is sponsored by Universitair Ziekenhuis Brussel and is currently Recruiting. The study focuses on Atrial Fibrillation. Target enrollment is 2000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Pulmonary vein isolation with the multielectrode radiofrequency balloon catheter
Observational
device
Sponsor & Location
Universitair Ziekenhuis Brussel
Timeline & Enrollment
N/A
Jan 01, 2021
Dec 01, 2030
Primary Outcome
Atrial arrhythmia recurrence after ablation,Procedural safety
Summary
All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing
 pulmonary vein isolation with the radiofrequency balloon catheter (RFB) Heliostar (Biosense
 Webster) will be included in a multicenter observational registry. The aim of the study is to
 assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a
 real-world setting.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06333327
Device Trial